Rapid detection of Yersinia pestis recombinant fraction 1 capsular antigen

Verfasser / Beitragende:
[Pei-Yi Tsui, Hui-Ping Tsai, Der-Jiang Chiao, Cheng-Che Liu, Rong-Hwa Shyu]
Ort, Verlag, Jahr:
2015
Enthalten in:
Applied Microbiology and Biotechnology, 99/18(2015-09-01), 7781-7789
Format:
Artikel (online)
ID: 605501211
LEADER caa a22 4500
001 605501211
003 CHVBK
005 20210128100559.0
007 cr unu---uuuuu
008 210128e20150901xx s 000 0 eng
024 7 0 |a 10.1007/s00253-015-6663-5  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00253-015-6663-5 
245 0 0 |a Rapid detection of Yersinia pestis recombinant fraction 1 capsular antigen  |h [Elektronische Daten]  |c [Pei-Yi Tsui, Hui-Ping Tsai, Der-Jiang Chiao, Cheng-Che Liu, Rong-Hwa Shyu] 
520 3 |a Yersinia pestis, an infectious bacterium that is a causative agent of plague, a disease which has been shown to be one of the most feared in history and which has caused millions of deaths. The capsule-like fraction 1 (F1) antigen expressed by Y. pestis is a known specific marker for the identification of the bacteria; therefore, the detection of F1 is important for Y. pestis recognition. In this study, a rapid, sensitive, and specific technique, the lateral flow assay (LFA), was successfully developed to detect Y. pestis by the recombinant F1 antigen. The assay that utilized an anti-F1 polyclonal antibody (Pab) to identify the bacteria was based on a double-antibody sandwich format on a nitrocellulose membrane. With the LFA method, 50ng/ml of recombinant F1 protein and 105 CFU/mL of Y. pestis could be detected in less than 10min. This assay also showed no cross-reaction with other Yersinia spp. or with some selected capsule-producing Enterobacteriaceae strains. Furthermore, detection of Y. pestis in simulated samples has been evaluated. The detection sensitivity of Y. pestis in various matrices was 105 CFU/mL, which was identical to that in PBS buffer. The results obtained suggest that LFA is an excellent tool for detection of Y. pestis contamination in an environment and hence can be used to monitor plague diseases when they emerge. 
540 |a Springer-Verlag Berlin Heidelberg, 2015 
690 7 |a Yersinia pestis  |2 nationallicence 
690 7 |a Capsule-like F1 antigen  |2 nationallicence 
690 7 |a Lateral flow assay  |2 nationallicence 
690 7 |a Immunogold detection  |2 nationallicence 
690 7 |a Mouse bioassay  |2 nationallicence 
700 1 |a Tsui  |D Pei-Yi  |u Institute of Preventive Medicine, National Defense Medical Center, P.O. Box 90048-700, Taipei, Taiwan, Republic of China  |4 aut 
700 1 |a Tsai  |D Hui-Ping  |u Institute of Preventive Medicine, National Defense Medical Center, P.O. Box 90048-700, Taipei, Taiwan, Republic of China  |4 aut 
700 1 |a Chiao  |D Der-Jiang  |u Institute of Preventive Medicine, National Defense Medical Center, P.O. Box 90048-700, Taipei, Taiwan, Republic of China  |4 aut 
700 1 |a Liu  |D Cheng-Che  |u Institute of Preventive Medicine, National Defense Medical Center, P.O. Box 90048-700, Taipei, Taiwan, Republic of China  |4 aut 
700 1 |a Shyu  |D Rong-Hwa  |u Institute of Preventive Medicine, National Defense Medical Center, P.O. Box 90048-700, Taipei, Taiwan, Republic of China  |4 aut 
773 0 |t Applied Microbiology and Biotechnology  |d Springer Berlin Heidelberg  |g 99/18(2015-09-01), 7781-7789  |x 0175-7598  |q 99:18<7781  |1 2015  |2 99  |o 253 
856 4 0 |u https://doi.org/10.1007/s00253-015-6663-5  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00253-015-6663-5  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Tsui  |D Pei-Yi  |u Institute of Preventive Medicine, National Defense Medical Center, P.O. Box 90048-700, Taipei, Taiwan, Republic of China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Tsai  |D Hui-Ping  |u Institute of Preventive Medicine, National Defense Medical Center, P.O. Box 90048-700, Taipei, Taiwan, Republic of China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Chiao  |D Der-Jiang  |u Institute of Preventive Medicine, National Defense Medical Center, P.O. Box 90048-700, Taipei, Taiwan, Republic of China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Liu  |D Cheng-Che  |u Institute of Preventive Medicine, National Defense Medical Center, P.O. Box 90048-700, Taipei, Taiwan, Republic of China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Shyu  |D Rong-Hwa  |u Institute of Preventive Medicine, National Defense Medical Center, P.O. Box 90048-700, Taipei, Taiwan, Republic of China  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Applied Microbiology and Biotechnology  |d Springer Berlin Heidelberg  |g 99/18(2015-09-01), 7781-7789  |x 0175-7598  |q 99:18<7781  |1 2015  |2 99  |o 253